tm logo
MEVORIG
FORMALIZED

on 12 Sep 2024

Last Applicant/ Owned by

Boehringer Ingelheim International GmbH

55218 Ingelheim

DE

Serial Number

2349340 filed on 01st Aug 2024

MEVORIG

Trademark usage description

pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, namely, renal diseases, liver diseases, pancreas diseases, digestive system disorders, gastrointestinal diseases and disorders, obesity; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs, namely, vascular diseases, hematology, blood disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, musculoskeletal diseases and disorders, central nervous system diseases and disorders, peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues, namely, rashes, sores, psoriasis, eczema; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections, namely, antibiotics, anti-infectives, antivirals; pharmaceutical preparations for the prevention and treatment of oncological diseases; pharmaceutical preparations for the prevention and treatment of auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of immunological diseases, namely, autoimmune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of infectious diseases, namely viral infections.


Classification kind code

12

Mark Details


Serial Number

2349340

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 12th Sep 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 12th Sep 2024
Created
Submitted for opposition 31
on 12th Sep 2024
Formalized
Submitted for opposition 228
on 01st Aug 2024
International Registration
Submitted for opposition 30
on 01st Aug 2024
Filed